# FDA Inspection 1269229 - Inner Mongolia Glint Pharmaceutical Co., Ltd. - March 27, 2025

Source: https://www.keypedia.com/records/fda_inspections/inner-mongolia-glint-pharmaceutical-co-ltd/6232afbb-84b4-45ef-beed-6763ea552740
Source feed: FDA_Inspections

> FDA Inspection 1269229 for Inner Mongolia Glint Pharmaceutical Co., Ltd. on March 27, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1269229
- Company Name: Inner Mongolia Glint Pharmaceutical Co., Ltd.
- Inspection Date: 2025-03-27
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1269229 - 2025-03-27](https://www.keypedia.com/records/fda_inspections/inner-mongolia-glint-pharmaceutical-co-ltd/b5375e9a-f496-4a7b-874d-85b46273b8d4)

Company: https://www.keypedia.com/companies/inner-mongolia-glint-pharmaceutical-co-ltd/2c36e2a1-769d-4ac8-a0be-a6f005d942be

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c